News & InsightsNewsletterLegislation Hub

Foresight

Foresight
AboutContactLog in
Book a Demo
Foresight logo
All News & Insights

EU Commission Approves 4-NPnEO, 4-tert-OPnEO REACH Authorisations

REACH
24
January 2024
•
352
Dr Steven Brennan
Authorised uses include cell extraction, chromatographic purification and solvent exchange and more.
Microscope on a table in a lab
Quick prompts

AI Generated

Get to the point quicker with prompts - a smarter way to get the information you need from our articles.

Summarise this article

AI Assistant

This feature and much more is available on our platform. If you would like early access, please leave your email and we'll get in touch.

We'll be in touch when the Assistant is ready.
Oops! Something went wrong while submitting the form.
Mountains

The European Commission has recently issued a series of important decisions regarding the authorisation of specific chemicals under the REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) Regulation. These decisions, outlined in documents C/2023/917 and C/2023/901, are pivotal for various industries, particularly in medical and scientific research sectors.

Under these decisions, authorisation has been granted for the use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (‘4-tert-OPnEO’) and 4-Nonylphenol, branched and linear, ethoxylated (4-NPnEO). These substances are now authorised for use in buffer solutions for a range of applications, including the production of purified proteins and quality control testing in laboratories. Such applications are essential in scientific research, development, and in vitro diagnostic procedures.

The authorisations have been granted to several companies, including Phadia GmbH, Thermo Fisher Scientific Baltics UAB, and Brahms GmbH. Additionally, RSI ChemRep Europe Ltd, representing OraSure Technologies Inc., has received authorisation for using 4-tert-OPnEO as a surfactant in in-vitro diagnostic device developer solutions for diagnosing Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV).

These decisions were made in accordance with Article 60(4) of the REACH Regulation, which states that the socio-economic benefits of using these substances outweigh the potential risks to human health and the environment. This highlights the European Commission's commitment to balancing the advancement of scientific and medical research with the need to protect health and the environment.

The review period for these authorisations is set until 4 January 2033, providing a significant duration for monitoring and evaluating the use of these substances. This period also allows for the potential development of safer and more environmentally friendly alternatives.

For companies in the chemical and pharmaceutical industries, understanding and adhering to these regulations is crucial. Foresight, with its deep expertise in chemical legislation, offers tailored solutions to assist businesses in navigating these complex regulatory environments. Our services ensure compliance with current regulations and prepare companies for future legislative changes, thereby reducing risks and enhancing operational effectiveness.

Stay informed about the latest in chemical legislation and discover how Foresight can support your compliance and risk management strategies by visiting our blog, Signal.

Read the source story

The European Commission has recently issued a series of important decisions regarding the authorisation of specific chemicals under the REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) Regulation. These decisions, outlined in documents C/2023/917 and C/2023/901, are pivotal for various industries, particularly in medical and scientific research sectors.

Read this article now for free!

You have read 3 articles.
Create a free account
or
Log in
to finish reading this article now.

Subscribe to our weekly digest

Sign up to receive our newsletter every Tuesday and get access to all of our content.

By creating an account, you agree to the Terms of Service and Privacy Policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
This is some text inside of a div block.

Trusted by professionals at

Dupont
ECHA - European Chemicals Agency
Energizer
Chemours
This is some text inside of a div block.

Get Foresight Today

Stay compliant, reduce risk, and protect your business with our AI-powered chemical policy monitoring—tailored just for you.

Global monitoring of 1,200+ sources
Expert-reviewed, trusted regulatory alerts
Instant risk identification for 350k+ substances

Ready to supercharge your policy monitoring workflow?

We’ll be in touch soon with more details and support to help you get started.
Oops! Something went wrong while submitting the form.
Share with a friend
Copy link

Related Articles

Paint coatingsReport Suggests Restrictions on Methylenedianilines Amid Carcinogenic and Environmental Concerns

May 9, 2025

Automotive chrome platingEU Proposes Chromium(VI) REACH Restriction to Safeguard Worker Health

May 2, 2025

Industrial coatingRegulatory Action Proposed for Amine-Terminated Aliphatic Ethers

April 17, 2025

Foresight regulatory experts
Streamline your chemical compliance
Easy-to-use product compliance management for small and mid-sized manufacturers — mitigate risk and protect market access.
Get started
Subscribe to Foresight's newsletter
Stay ahead with the latest news & insights
Join 1,000s of compliance professionals getting the latest insights right to their inbox for free, every Tuesday.
100% free. No spam. Unsubscribe any time.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Stay ahead with the latest news & insights
Subscribe to our free weekly newsletter covering news, events, and expert insights.

Related articles

Paint coatings

Report Suggests Restrictions on Methylenedianilines Amid Carcinogenic and Environmental Concerns

ECHA flags methylenedianilines for potential restrictions in EU due to health and environmental risks; industry urged to monitor developments.

9

May 2025

REACH
Automotive chrome plating

EU Proposes Chromium(VI) REACH Restriction to Safeguard Worker Health

The EU's proposed Chromium(VI) restriction could reshape REACH compliance and exposure controls across industry. Learn what it means for your business.

2

May 2025

REACH
Industrial coating

Regulatory Action Proposed for Amine-Terminated Aliphatic Ethers

ECHA proposes compliance checks and future restrictions for amine-terminated aliphatic ethers. Understand how this affects your regulatory obligations.

17

Apr 2025

REACH
CLP
Foresight
Providing critical insights, analysis, and guidance to help businesses anticipate changes, make informed decisions, and stay ahead.
News & Insights
Newsletter
Legislation Hub
Coverage
Contact
About
© 2025 Foresight. All rights reserved.
SitemapTerms of servicePrivacy policyCookie policy